Q1: Subsequent Transplant or Cellular Therapy

Question 1: Is this the report of a second or subsequent infusion?

Report No and go to question 2 in any of the following scenarios:

• This is the first infusion reported to the CIBMTR; or
• This is a second or subsequent infusion for a different disease (i.e., the patient was previously transplanted for a disease other than Sickle Cell Disease); or
• This is a second or subsequent infusion for the same disease subtype and this baseline disease insert was not completed for the previous transplant (i.e., the patient was on the TED track for the prior infusion, prior infusion was autologous with no consent, etc.).
  

Report Yes and go to question 6 if this is a subsequent infusion for the same disease and the baseline SCD disease insert was completed previously.

Section Updates:

Question Number	Date of Change	Add/Remove/Modify	Description	Reasoning (If applicable)
.	.	.	.	.

Copyright © 2004-2024 The Medical College of Wisconsin, Inc. and NMDP. All Rights Reserved.
CIBMTR® (Center for International Blood and Marrow Transplant Research) is a research collaboration between the Medical College of Wisconsin and NMDP.